Concourse Financial Group Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MCM
FCBT
Concourse Financial Group Securities's XPH Position: Q1 2023 in Review
Concourse Financial Group Securities sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2023, closing a stake of 172 shares — an estimated $7.23K sold.
Concourse Financial Group Securities first reported a position in XPH in Q4 2018 and held it in 16 quarters. The position peaked at $235K in Q1 2019. 61 funds tracked by Wall St. Rank hold XPH as of Q1 2023.
- Concourse Financial Group Securities reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
- Concourse Financial Group Securities sold 172 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2023, an estimated $7.23K.
- Concourse Financial Group Securities first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2018 and held it in 16 quarters.
- Concourse Financial Group Securities's State Street SPDR S&P Pharmaceuticals ETF position peaked at $235K in Q1 2019.
- 61 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2023.
Based on Concourse Financial Group Securities's 13F filing for Q1 2023, filed 15 May 2023.